Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feederroche.com
Roche Media News
Get the latest updates from Roche Media News directly as they happen.
Follow now 327 followers
Latest posts
Last updated 4 days ago
[Ad hoc announcement pursuant to Art. 53 LR] Roche’s divarasib shows superiority in head-to-head phase III trial against approved KRAS G12C inhibitors in non-small cell lung cancer
4 days ago
Phase III (Krascendo 1) demonstrates best-in-class potential for patients with previously treated...
FDA grants Priority Review to Roche’s Enspryng, the first and only at-home subcutaneous treatment option for thyroid eye disease (TED)
6 days ago
The filing application is based on improvements seen across key efficacy endpoints...
Roche announces the launch of AXELIOS 1, a transformative next-generation sequencing platform
7 days ago
AXELIOS 1 delivers a unique combination of accuracy, speed, scalability and cost...
FDA accepts supplemental Biologics License Application for Roche’s Lunsumio and Polivy combination for people with relapsed or refractory large B-cell lymphoma
18 days ago
Filing acceptance based on data from the phase III SUNMO study where...
Roche receives FDA approval for the first companion diagnostic to assess PTEN protein in people living with prostate cancer
24 days ago
The new VENTANA PTEN (SP218) RxDx Assay fulfils an unmet medical need...
FDA grants Priority Review for Roche’s Tecentriq for a certain type of stage III colon cancer
25 days ago
Filing acceptance is based on the phase III Alliance ATOMIC study showing...
Roche announces global collaboration with Nurix Therapeutics to co-develop and co-commercialise potential best-in-class BTK degrader bexobrutideg across malignant haematology, immunology and neurology
28 days ago
Agreement offers potential best-in-class targeted protein degrader therapy option for people living...
FDA accepts New Drug Application for Roche’s giredestrant in ER-positive early-stage breast cancer, the first and only oral SERD with positive phase III results in the curative setting
about 1 month ago
Filing acceptance, under priority review, based on phase III data showing giredestrant...
Roche to present new data advancing its obesity portfolio at the American Diabetes Association’s 2026 Scientific Sessions
about 1 month ago
Late-breaking Phase II data highlight enicepatide’s (CT-388) efficacy and safety, reinforcing its...
Roche launches the Liver Disease Panel, the first suite of certified algorithms to support Chronic Liver Disease management
about 1 month ago
Roche introduces the first comprehensive library of certified healthcare algorithms to support...
Roche to present new data at ASCO 2026, reinforcing giredestrant's potential to transform the treatment paradigm in early breast cancer
about 2 months ago
New giredestrant data from the lidERA study on its potential as a...
Roche receives CE mark for new blood test to detect Alzheimer's pathology: Elecsys® plasma phosphorylated-tau 217 (pTau217)
about 2 months ago
Elecsys® pTau217 is the first blood test for Alzheimer’s disease pathology with...